CN Patent

CN109674795A — 伊曲康唑组合物和剂型及其使用方法

Assigned to Mayne Pharma International Pty Ltd · Expires 2019-04-26 · 7y expired

What this patent protects

本申请涉及伊曲康唑组合物和剂型及其使用方法。除其他方面之外，本披露涉及包含伊曲康唑的药物组合物如固体口服剂型、制备这些组合物的方法、以及使用它们治疗包括但不限于真菌感染的病症的方法。

USPTO Abstract

本申请涉及伊曲康唑组合物和剂型及其使用方法。除其他方面之外，本披露涉及包含伊曲康唑的药物组合物如固体口服剂型、制备这些组合物的方法、以及使用它们治疗包括但不限于真菌感染的病症的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN109674795A
Jurisdiction
CN
Classification
—
Expires
2019-04-26
Drug substance claim
No
Drug product claim
No
Assignee
Mayne Pharma International Pty Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.